Adoptive Cellular Therapy of T Cell Lymphoma

$1.96M USD

Funder	NATIONAL CANCER INSTITUTE
Recipient Organization	Yale University
Country	United States
Start Date	Jul 01, 2021
End Date	Jun 30, 2023
Duration	729 days
Number of Grantees	2
Roles	Principal Investigator; Co-Investigator
Data Source	NIH (US)
Grant ID	`10290516`

Grant Description

PROJECT SUMMARY Peripheral T cell lymphomas (PTCL) are a highly heterogeneous group of neoplasms that account for 10-30% of all Non-Hodgkin Lymphomas.

Of these, angioimmunoblastic T cell lymphoma (AITL), PTCL NOS (not otherwise specified), and Sezary syndrome (SS) are particularly aggressive with 5-year survivals of